Self-monitoring Blood Glucose Devices Market – By Product, By Application, By End Use – Global Forecast, 2025 – 2034

The U.S. market was valued at USD 6.4 billion in 2023 and is projected to reach USD 20.3 billion by 2034.

Some of the eminent market participants include Abbott Laboratories, AgaMatrix, All Medicus, Arkray, Ascensia Diabetes Care Holdings, B. Braun Melsungen, Bionime Corporation, DarioHealth, F. Hoffmann-La Roche, LifeScan, Nova Biomedical, Omnis Health, Sanofi, Sinocare, and Ypsomed Holding.

The consumables segment held a leading position in the market, accounting for USD 11.1 billion in 2024.

The global market size for self-monitoring blood glucose monitoring devices was valued at USD 19.8 billion in 2024 and is expected to reach USD 58.9 billion in 2034, growing at a CAGR of 11.8% from 2025 to 2034.